Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoid Tumor × telotristat ethyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Serotonin Syndrome 3 Neuroendocrine Tumors 3 Pancreatic Neoplasms 1 Neoplasms 1 Diarrhea 1 Carcinoid Tumor 1 Carcinoid Heart Disease 1 Cachexia 1

Interventions

gallium Ga 68 dotatate 2 veliparib 1 telotristat ethyl 1 Temozolomide 1 Panitumumab 1 Octreotide 1 Capecitabine 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04672876 2021-12-17

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors

University of Chicago

Phase 2 Withdrawn

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡